+36.1%
MRNA vs FLNC
-62.9%
+98.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FLNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.5% | +2.9% | +4.9% |
| 7D | -1.1% | -4.1% | +3.0% | -0.5% |
| 30D | +126.1% | -24.8% | +150.9% | +138.4% |
| 3M | +190.0% | -59.1% | +249.1% | +233.2% |
| 6M | +157.2% | -42.0% | +199.2% | +167.6% |
| YTD | +388.2% | -49.8% | +438.0% | +408.1% |
| 1Y | +467.0% | +43.1% | +424.0% | +361.5% |
| 3Y | +36.1% | -61.0% | +97.0% | +24.0% |
| All | +36.1% | -62.9% | +98.9% | +24.0% |
Cumulative growth
Daily Returns
Daily percentage return beside FLNC.
Daily Out/Under-Performance
Portfolio return minus FLNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FLNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FLNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling